AzTrials
AzTrials

Airway Complication of AnaesthesiaNCT02322684

Endotracheal Intubation Using a Bougie Through the Air-Q Intubating Laryngeal Airway

A study testing Air-Q in people with Airway Complication of Anaesthesia, run by Theodor Bilharz Research Institute at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the success rate of bougie-guided endotracheal intubation compared to blind intubation through the Air-Q intubating laryngeal mask Read more about this study

Who is it for?
Ages 19 to 60 years
Conditions the study is for
Airway Complication of Anaesthesia
What is being tested?
Air-Q
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteEgypt
Study dates
Jan 2015to Jul 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 19-60 years old,
  • ASA physical status I and II
  • Patients scheduled to receive general anesthesia with tracheal intubation for an elective surgical procedure.

Who cannot join

  • Age <19 \& >60
  • ASA physical status ≥ III,
  • Mouth opening <2 cm,
  • Patients with increased risk of aspiration,
  • Those with poor lung compliance,
  • Patients with lesions of the oropharynx or epiglottis
  • Patients known or anticipated to have difficult tracheal intubation or facemask ventilation.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Theodor Bilharz Research Institute

    Giza, 12411

Other trials in Egypt

About this study

Official title: Bougie-guided Tracheal Tube Placement Through the Air-Q® Intubating Laryngeal Airway: Clinical Evaluation

The purpose of this study is to assess the success rate of bougie-guided endotracheal intubation compared to blind intubation through the Air-Q intubating laryngeal mask

Read the detailed description

After ethical committee approval and written informed consent, 140 patients of either sex, > 18 years old, ASA physical status I and II scheduled to receive general anesthesia with tracheal intubation for an elective surgical procedure will be enrolled in the study. They will be randomly allocated to one of two groups according to a computer generated list of 70 patients each. Blind endotracheal intubation will be performed through the air-Q with bougie assisted (Group B) or without assistance (Group Q). Patients ASA physical status >III, mouth opening <2 cm, increased risk of aspiration, those with poor lung compliance, with lesions of the oropharynx or epiglottis and known or anticipated difficult tracheal intubation or facemask ventilation will be excluded from the study.

In the operating room, the following monitors will be attached to the patients: five leads ECG, noninvasive blood pressure, pulse oximetry, ETCO2, anesthetic gas analyzer and neuromuscular monitoring (Infinity Kappa, Dräger, Lübeck, Germany). After adequate oxygenation, general anesthesia will be induced with 2 mg kg-1 propofol, 1-2 µg kg-1 fentanyl and 0.6 mg kg-1 rocuronium. Mask-ventilation with a mixture of oxygen and sevoflurane for an end-tidal concentration of 2% will be followed. The air-Q/ILA will be inserted once ulnar nerve train-of-four stimulation produced no visually detectable response while the patient's head in a neutral position. All airway manipulations (device insertion and tracheal intubation) will be performed by a senior anesthesiology staff member. The size of the air-Q will be selected on the basis of the patient's weight, in accordance with the corresponding manufacturer's recommendations. If ventilation with the device is unsatisfactory, the "Klein maneuver" corrects downfolding of the epiglottis by using a jaw thrust and an up-down maneuver of the ILA. During tracheal intubation through the air-Q/ILA, the tracheal tube is advanced to a depth of 12 to 15 cm so that the tip of the tube is close to the air-Q/ILA opening. Intubation through these supraglottic devices will be facilitated using a water-based lubricant. Then removal of the ILA immediately after tracheal intubation can be assisted by a stylet produced by the manufacturer. Tracheal intubation will be successful if ventilation through the tracheal tube produced an adequate chest expansion and a capnographic curve is obtained.

In group B, the operator gently inserts the bougie through the air-Q/ILA while looking at any bulges in the neck to judge the approximate positioning of the bougie. As soon as the bougie enters the trachea, a characteristic click is felt by the assistant and the operator feels the bougie entering in a hallow space. Another sign for intra tracheal bougie insertion when the bougie reaches the small bronchus between 30 and 40 cm marks (distal hold up sign). The air-Q/ILA is then removed and a tracheal tube is railroaded over the bougie.

Conventional single-use polyvinyl chloride (PVC) tracheal tubes (Mallinckrodt Company, Juarez, Chihuahua, Mexico) will be used for blind tracheal intubation in both groups: size 7.0 mm ID tracheal tubes for patients weighing ≥50 kg and 6.0 mm ID tubes for patients <50 kg. In both study groups, 3 attempts at device insertion and intubation will be allowed. Intubation will be only attempted if appropriate ventilation is obtained. Lung ventilation through the supraglottic device is permitted between intubation attempts. If tracheal intubation through the device is unsuccessful, it is performed by direct laryngoscopy.

The following parameters will be measured:

  • Mallampati score, mouth opening (cm), thyromental distance (cm), neck circumference (cm)
  • Air-Q™ /ILA insertion: insertion time (seconds), ease of insertion (easy, difficult), number of attempts, 1st attempt success rate and grade of ventilation (adequate, possible or impossible).
  • Tracheal intubation: number of attempts, intubation time (seconds), 1st attempt success rate and overall success rate, ,
  • Air-Q insertion time: is the time from introducing the device in mouth till attachment to the circuit and capnographic trace is obtained.
  • Bougie insertion time: is the time from removal of the breathing circuit from air-Q to the feeling of hold up sign.
  • ETT insertion time: is the time from insertion of the tracheal tube in the device until confirmation by capnographic trace.
  • Total intubation time in group Q (air-Q™ /ILA insertion time plus intubation time) and the total intubation time in group B (air-Q™ /ILA insertion time plus bougie insertion time plus bougie guided intubation time) were calculated.
  • We also recorded the types of and number of adjusting maneuvers for each attempt, frequency of esophageal intubation, and any incidence of hypoxia (SpO2<95%).
  • Incidence of airway complications at insertion of air-Q™ /ILA, gum elastic bougie and ETT as trauma to mouth, lips or tongue and visible or occult blood.
  • Incidence of Airway Morbidity at 18-24 h postoperatively in both groups as sore throat, dysphagia, dysphonia and its degree (mild/moderate/severe)
  • Hemodynamic data heart rate (HR) and mean arterial blood pressure (MAP) were also recorded at the following time intervals:

T0, baseline before induction T1, before air-Q™ insertion T2, after air-Q™ insertion T3, before bougie insertion T4, after bougie insertion T5, before ETT insertion through the device T6, after ETT intubation T7, 1 min after intubation T8, 5 min after intubation T9, 10 min after intubation

Statistical Analysis

As no previous study researching bougie guided endotracheal intubation through air-Q™, we consider this research as a pilot study and 70 patients in each group is suitable. Results are expressed as mean ± standard deviation (SD) or number (%). Categorical data was compared using Chi square test. Variables in both groups were compared using either unpaired t test or Mann Whitney test whenever it was appropriate. Intra-group comparison (within group comparison) between mean values of variables measured at baseline and different times was performed using repeated measures ANOVA followed by Bonferroni test if significant results was recorded. Data analysis was performed using Statistical Package for Social Sciences (SPSS) version 19 computer program. Significance was considered when P-value ≤ 0.05.

Being tested
Air-Q
Keywords
Bougie, Air-Q, Insertion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Air-QDevice

    Also called Intubating laryngeal Airway

    Air-Q/Intubating Laryngeal Airway (air-Q/ILA, Cookgas LLC, St. Louis, MO, USA) is an extra glottis airway (EGA) used as a primary airway device or as an adjunct to tracheal intubation. The air-Q/ILA is available as a disposable (air-Q) or nondisposable (ILA) device

Study groups in NCT02322684
Study groupRoleWhat they receive
Group QActive comparatorBlind endotracheal intubation will be performed through the air-Q
Receives: Device: Air-Q
Group BActive comparatorBlind endotracheal intubation will be performed through the air-Q with bougie assisted
Receives: Device: Air-Q

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess bougie-guided tracheal tube placement through the air-Q® Intubating Laryngeal Airway regarding success rate on the first attempt

    The operator gently inserts the bougie through the air-Q/ILA while looking at any bulges in the neck to judge the approximate positioning of the bougie. As soon as the bougie enters the trachea, a characteristic click is felt by the assistant and the operator feels the bougie entering in a hallow space. Another sign for intra tracheal bougie insertion when the bougie reaches the small bronchus between 30 and 40 cm marks (distal hold up sign). The air-Q/ILA is then removed and a tracheal tube is railroaded over the bougie.

    Measured: Three attempts are allowed (up to 5 minutes)

Secondary outcomes (2)
  1. The overall success rate

    The air-Q/ILA insertion and endotracheal insertion success rate (1st+2nd+3rd attempts)

    Measured: 5 minutes

  2. The tracheal intubation time

    It is the calculated from the insertion of the tracheal tube in the device until confirmation of adequate lung ventilation

    Measured: 1 minute

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2014 (estimated)
  2. Study startJan 2015
  3. Primary completionJun 2016
  4. Study completionJul 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02322684
Sponsor's protocol ID
TBRI-airq
Status last verified
Oct 2016
First submitted
15 Dec 2014
Last updated
19 Oct 2016
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Air-Q in people with Airway Complication of Anaesthesia, run by Theodor Bilharz Research Institute at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess bougie-guided tracheal tube placement through the air-Q® Intubating Laryngeal Airway regarding success rate on the first attempt (time frame: Three attempts are allowed (up to 5 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in